Upcoming events

Follow Us

Menu
Log in


Log in


CLAE 2021 Scientific Meeting- Speaker & Planning Committee Agreement Form

  • 24 Sep 2021
  • 26 Sep 2021
  • Virtual

Registration


Registration is closed

This form is collecting the following: 

  1. Conflict of Interest Declaration for Accreditation 
  2. CFPC Disclosure Slide (For speakers: first fill out your CFPC disclosure slide before completing the electronic conflict-of-interest (COI) form.
  3. 2-3 sentence speaker bio for introductory purposes
  4. Speaker headshot (Headshots may be used for Scientific Meeting promotion and are not mandatory)
  5. Speaker Release for Video and Audio Recording

Click REGISTER in the left-hand column, once you are ready to complete your form.

The National Standard for Support of Accredited CPD Activities (the National Standard) describes the process and requirements for gathering, managing, and disclosing conflicts of interest to participants. The National Standard is applicable to all accredited CPD activities included within the Canadian national/provincial CME/CPD accreditation systems for physicians.

Definitions:

Conflict of interest: A conflict of interest is a set of conditions in which judgement or decisions concerning a primary interest (example a patients’ welfare, the validity of research and/or quality of medical education) is unduly influenced by a secondary interest (personal or organizational benefit including financial gain, academic or career advancement, or other benefits to family, friends, or colleagues).

Perceived conflict of interest: A perceived conflict of interest is the appearance of a conflict of interest as judged by outside observers regardless of whether an actual conflict of interest exists

Real conflict of interest: A real conflict of interest is when two or more interests are indisputably in conflict.

National Standard Element 3: Conflict of Interest

This element describes the processes and requirements for gathering, managing and disclosing conflicts of interest to participants.

3.1 All members of the scientific planning committee (SPC), speakers, moderators, facilitators and authors must provide to the CPD provider organization a written description of all relationships with for-profit and not-for-profit organizations over the previous 2 years including (but not necessarily limited to):

  • a) Any direct financial payments including receipt of honoraria;
  • b) Membership on advisory boards or speakers’ bureaus;
  • c) Funded grants or clinical trials;
  • d) Patents on a drug, product or device; and
  • e) All other investments or relationships that could be seen by a reasonable, well informed participant as having the potential to influence the content of the educational activity.

3.2 The SPC is responsible to review all disclosed financial relationships of speakers, moderators, facilitators and authors in advance of the CPD activity to determine whether action is required to manage potential or real conflicts of interest. The SPC must also have procedures in place to be followed if a conflict of interest comes to its attention prior to or during the CPD activity.

3.3 All members of the SPC, speakers, moderators, facilitators, and authors, must disclose to participants their relationships as described in 3.1.

3.4 Any individual who fails to disclose their relationships as described in 3.1 and 3.3 cannot participate as a member of the SPC, speaker, moderator, facilitator or author of an accredited CPD activity.

COI Disclosure Process

1.   Complete the conflict of interest disclosure form and submit to the CPD provider organization or scientific planning committee, as directed.

2.   Disclosures must be made to the audience whether you do or do not have a relationship to disclose.

3.   Speakers must disclose conflicts verbally and in writing on a slide at the beginning of a presentation. All other individual’s conflicts must be disclosed either in writing on a slide at the beginning of a presentation or be included in the written conference materials

4.   Those responsible for developing or delivering content must ensure that the content and/or materials presented provide (where applicable) a balanced view across all relevant options related to the content area.

5.   The description of therapeutic options must utilize generic names (or both generic and trade names) and not reflect exclusivity and branding.

Powered by Wild Apricot Membership Software